India’s healthcare and chemicals sectors are entering a pivotal growth phase, with brokerages turning increasingly selective yet optimistic on marquee names. Goldman Sachs has rolled out a mix of Buy and Neutral calls on key players including KIMS, Max Healthcare, Fortis, and Apollo Hospitals, based on growth visibility, execution strength, and sectoral dynamics. In parallel, Equirus has highlighted a medium-term revival narrative for SRF Ltd,
